Zhengliang Tu

79 Qingchun Road
Hangzhou, 310003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

ASO Visual Abstract: A Prospective Multicenter Comparative Cohort Study of Neoadjuvant Sintilimab Plus Chemotherapy and Chemoradiotherapy in Resectable Clinical Node-Positive Esophageal Squamous Cell Carcinoma.

ASO Visual Abstract: A Prospective Multicenter Comparative Cohort Study of Neoadjuvant Sintilimab Plus Chemotherapy and Chemoradiotherapy in Resectable Clinical Node-Positive Esophageal Squamous Cell Carcinoma.

Journal: Annals of surgical oncology

Published: July 20, 2026

A Prospective Multicenter Comparative Cohort Study of Neoadjuvant Sintilimab Plus Chemotherapy and Chemoradiotherapy in Resectable Clinical Node-Positive Esophageal Squamous Cell Carcinoma.

A Prospective Multicenter Comparative Cohort Study of Neoadjuvant Sintilimab Plus Chemotherapy and Chemoradiotherapy in Resectable Clinical Node-Positive Esophageal Squamous Cell Carcinoma.

Journal: Annals of surgical oncology

Published: January 21, 2026

Macrophage-delivered Nifuroxazide reprograms immunosuppressive microenvironment and synergizes with oxaliplatin for enhanced anti-hepatocellular carcinoma therapy.

Macrophage-delivered Nifuroxazide reprograms immunosuppressive microenvironment and synergizes with oxaliplatin for enhanced anti-hepatocellular carcinoma therapy.

Journal: Journal of nanobiotechnology

Published: October 02, 2025

Non-canonical NOTCH1 signaling regulates ferroptosis vulnerability in dormant lung cancer cells with stable resistance.

Non-canonical NOTCH1 signaling regulates ferroptosis vulnerability in dormant lung cancer cells with stable resistance.

Journal: Cell death & disease

Published: January 19, 2025

Super-enhancer-associated circPVT1 promotes malignancy of hepatocellular carcinoma via YBX1-mediated RRM2 activation.

Super-enhancer-associated circPVT1 promotes malignancy of hepatocellular carcinoma via YBX1-mediated RRM2 activation.

Journal: Cancer letters

Published: February 08, 2024

Cell-free DNA methylation profile potential in the diagnosis of lung squamous cell carcinoma.

Cell-free DNA methylation profile potential in the diagnosis of lung squamous cell carcinoma.

Journal: Journal of thoracic disease

Published: December 01, 2023

Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC.

Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC.

Journal: BMC cancer

Published: August 22, 2023

Optimizing perioperative treatment for potentially resectable stage III squamous cell lung carcinoma: promising results of a condensed four-cycle regimen with tislelizumaband chemotherapy.

Optimizing perioperative treatment for potentially resectable stage III squamous cell lung carcinoma: promising results of a condensed four-cycle regimen with tislelizumaband chemotherapy.

Journal: BMC medicine

Published: July 18, 2023

Uniportal video-assisted thoracoscopic surgery and robot-assisted thoracoscopic surgery are feasible approaches with potential advantages in minimally invasive mediastinal lesions resection.

Uniportal video-assisted thoracoscopic surgery and robot-assisted thoracoscopic surgery are feasible approaches with potential advantages in minimally invasive mediastinal lesions resection.

Journal: Gland surgery

Published: February 26, 2021

Exploration of Prognostic Biomarkers for Lung Adenocarcinoma Through Bioinformatics Analysis.

Exploration of Prognostic Biomarkers for Lung Adenocarcinoma Through Bioinformatics Analysis.

Journal: Frontiers in genetics

Published: January 07, 2021

Simultaneous uniportal video-assisted thoracic surgery for pulmonary nodules and synchronous mediastinal lesions.

Simultaneous uniportal video-assisted thoracic surgery for pulmonary nodules and synchronous mediastinal lesions.

Journal: Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques

Published: September 13, 2020

Study on the Application of A New Type of Anhydrous Thoracic Negative Pressure Drainage Device in Patients after Thoracic Surgery

Study on the Application of A New Type of Anhydrous Thoracic Negative Pressure Drainage Device in Patients after Thoracic Surgery

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: June 11, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026